Anderson, I. (1997) Lessons to be learnt from meta-analyses of newer versus older antidepressants. Advances in Psychiatric Treatment, 3, 58–63.
Anderson, I. M. & Edwards, J. G. (200l) Guidelines for choice of selective serotonin reuptake inhibitor in depressive illness. Advances in Psychiatric Treatment, 7, 170–180.
Anderson, I. & Tomenson, B. M. (1995) Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ, 310, 1433–1438.
Baker, C. B., Johnsrud, M. T., Crismon, M. L.
et al (2003) Quantitative analysis of sponsorship bias in economic studies of antidepressants. British Journal of Psychiatry, 183, 498–506.
Baldwin, D. S. (2004) Sexual dysfunction associated with antidepressant drugs. Expert Opinion in Drug Safety, 3, 457–470.
Barbey, J. T. & Roose, S. P. (1998) SSRI safety in overdose. Journal of Clinical Psychiatry, 59 (suppl. 15), 42–48.
Barbui, C., Hotopf, M., Freemantle, N.
et al (2000) Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Library, issue 4. Oxford: UpdateSoftware.
Borys, D. J., Setzer, S. C., Ling, L. J.
et al (1992) Acute fluoxetine overdose: a report of 234 cases. American Journal of Emergency Medicine, 10, 115–120.
British Medical Association & Royal Pharmaceutical Society of Great Britain (2004) British National Formulary 47. London & Wallingford: BMJ Books & Pharmaceutical Press.
Buckley, N. A. & McManus, P. R. (2002) Fatal toxicity of serotonergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ, 325, 1332–1333.
Cheeta, S., Schifano, F., Oyefesco, A.
et al (2004) Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998–2000. British Journal of Psychiatry, 184, 41–47.
Denchant, K. L. & Clissold, S. P. (199l) Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs, 41, 225–253.
Donovan, S., McGrady, H., Pownall, R.
et al (1993) The efficacy and tolerability of dothiepin and three selective serotonin reuptake inhibitors in the treatment of major depression: a review of six double-blind studies. Current Therapeutic Research, 54, 275–288.
Dunbar, G. C., Cohn, J. B., Fabre, L. F.
et al (199l) A comparison of paroxetine, imipramine and placebo in depressed out-patients. British Journal of Psychiatry, 159, 394–398.
Edwards, J. G. (1995) Drug choice in depression. Selective serotonin reuptake inhibitors or tricyclic antidepressants?
CNS Drugs, 4, 141–159.
Edwards, J. G. (1997) Prevention of relapse and recurrence of depression: newer versus older antidepressants. Advances in Psychiatric Treatment, 3, 52–57.
Edwards, J. G. (2004a) Unwanted effects of psychotropic drugs. 1. Effects on human physiological systems, mechanisms and methods of assessment. In Seminars in Clinical Psychopharmacology (2nd edn) (ed. King, D. J.) pp. 573–600. London: Gaskell.
Edwards, J. G. (2004b) Unwanted effects of psychotropic drugs. 2. Drug interactions, effects during pregnancy and breastfeeding, pharmaco-vigilance and medico-legal considerations. In Seminars in Clinical Psychopharmacology (2nd edn) (ed. King, D. J.) pp. 601–660. London: Gaskell.
Edwards, J. G. & Anderson, I. (1999) Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs, 57, 507–533.
Edwards, J. G., Inman, W. H. W., Wilton, L.
et al (1997) Drug safety monitoring of 12692 patients treated with fluoxetine
Human Psychopharmacology, 12, 127–137.
Geddes, J. R., Carney, S. M., Davies, C.
et al (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet, 361, 653–661.
Glassman, A. H. (1997) Citalopram toxicity. Lancet, 350, 818.
Goldstein, D. J. & Sundell, K. (1999) A review of the safety of selective serotonin reuptake inhibitors during pregnancy. Human Psychopharmacology, 14, 319–324.
Hendrick, V., Fukuchi, A., Altshuler, L.
et al (200l) Use of sertraline, paroxetine and fluvoxamine by nursing women. British Journal of Psychiatry, 179, 163–166.
Henry, J.A. (199l) Overdose and safety with fluvoxamine. International Clinical Psychopharmacology, 6 (suppl. 3), 41–45.
Henry, J. A. (1997) Toxicity of newer versus older antidepressants. Advances in Psychiatric Treatment, 3, 41–45.
Henry, J. A., Alexander, C. A. & Sener, E. K. (1995) Relative mortality from overdose of antidepressants. BMJ, 310, 221–224.
Isacsson, G. & Bergman, U. (1996) Risks with citalopram in perspective, Lancet, 348, 1033.
Isacsson, G., Redfors, I., Wasserman, D.
et al (1994) Choice of antidepressants: questionnaire survey of psychiatrists and general practitioners in two areas of Sweden. BMJ, 309, 1546–1549.
Jick, S. S., Dean, A. D. & Jick, H. (1995) Antidepressants and suicide. BMJ, 310, 215–218.
Kessing, L. V., Andersen, P. K., Mortensen, P. B.
et al (1998) Recurrence of affective disorder. I. Case register study. British Journal of Psychiatry, 172, 23–28.
Kessing, L. V., Hansen, M. G. & Andersen, P. K. (2004) Course of illness in depressive and bipolar disorders. Naturalistic study, 1994–1999. British Journal of Psychiatry, 185, 372–377.
Klein-Schwartz, W. & Anderson, B. (1996) Analysis of sertraline-only overdoses. American Journal of Emergency Medicine, 14, 456–458.
Lee, A. S. & Murray, R. M. (1988) The long-term outcome of Maudsley depressives. British Journal of Psychiatry, 153, 74l–75l.
Liu, B., Anderson, G., Mittman, N.
et al (1998) Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet, 351, 1303–1307.
MacGillivay, S., Arroll, B., Hatcher, S.
et al (2003) Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis, BMJ, 326, 1014–1017.
Mackay, F. J., Dunn, N. R., Wilton, L. V.
et al (1997) A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiology and Drug Safety, 6, 235–246.
Montgomery, S. A. & Kasper, S. (1995) Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. International Clinical Psychopharmacology, 9 (suppl. 4), 33–40.
Nemeroff, C. B. (2003) Overview of the safety of citalopram, Psychopharmacology Bulletin, 37, 96–121.
Office of Population Censuses and Surveys (1975–1992) Mortality Statistics. Cause. Reviews of the Registrar General on Deaths by Cause, Sex and Age, in England and Wales. London: HMSO.
Olver, J. S., Burrows, G. D. & Norman, T. R. (200l) Third-generation antidepressants. Do they offer advantages over the SSRIs?
CNS Drugs, 15, 941–954.
Ostrom, M., Eriksson, A., Thorson, J.
et al (1996) Fatal overdose with citalopram. Lancet, 348, 339–440.
Personne, M., Sjoberg, G. & Persson, H. (1997) Citalopram overdose – review of cases treated in Swedish hospitals. Journal of Toxicology and Clinical Toxicology, 35, 237–240.
Piccinelli, M. & Wikinson, G. (1994) Outcome of depression in psychiatric settings. British Journal of Psychiatry, 164, 297–304.
Pirraglia, P.A., Rosen, A.B., Hermann, R.C.
et al (2004) Cost–utility analysis studies of depression management: a systematic review. American Journal of Psychiatry, 161, 2155–2162.
Sarko, J. (2000) Antidepressants, old and new. A review of their adverse effects and toxicity in overdose. Pharmacological Advances in Emergency Medicine, 18, 637–654.
Shah, R., Uren, Z., Baker, A.
et al (2001) Deaths from antidepressants in England and Wales 1993–1997: analysis of a new national database. Psychological Medicine, 31, 1203–1210.
Simon, G.E., VonKorff, M., Heiligenstein, J.H.
et al (1996) Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. Journal of the American Medical Association, 275, 1897–1902.
Spijker, J., de Graff, R., Bijl, B. V.
et al (2002) Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS), British Journal of Psychiatry, 181, 208–213.
Teicher, M. H., Glod, C. & Cole, J. O. (1990) Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry, 147, 207–210.
Trindale, E. & Menon, D. (1997) Selective Srotonin Reuptake Inhibitors (SSRIs) for Major Depression. Part I. Evaluation of the Clinical Literature. Technology Assessment, Report 3E. Ottawa: Canadian Coordinating Office for Health.
Van Larr, M. W., van Willgenburg, A. P. P. & Vokerts, E. R. (1995) Acute and subchronic effects of nefazodone and imipramine on highway driving cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. Journal of Clinical Pharmacology, 15, 30–40.
Wilton, L. V., Pearce, G. L., Martin, R. M.
et al (1998) The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. British Journal of Obstetrics and Gynaecology, 105, 882–889.
Yoshida, K., Smith, B. & Kumar, R. (1999) Psychotropic drugs in mother's milk: a comprehensive review of assay methods, pharmacokinetics and of safety in breastfeeding. Journal of Psychopharmacology, 131, 64–80.